1 / 6

telegra.ph-List of Major 3 Newsletters of DelveInsight

DelveInsight presents a new addition to its newsletter edition that focuses on the Prostate Cancer market. The newsletter offers a complete picture of the Prostate Cancer market landscape, ongoing clinical trials, pipeline therapies that are expected to transform the Prostate Cancer market in the coming decade. Gain rich insights into Prostate Cancer epidemiological insights, current treatment therapies, details of the latest news and happenings, mergers and collaborations, critical pharmaceuticals involved, licensing deals along with events and top-level conferences taking place in the Prosta

yashb
Download Presentation

telegra.ph-List of Major 3 Newsletters of DelveInsight

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. List of Major 3 Newsletters of DelveInsight telegra.ph/List-of-Major-3-Newsletters-of-DelveInsight-10-04 Prostate Cancer Newsletter 1. Prostate Cancer Newsletter Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prostate Cancers grow slowly and remain confined to the prostate gland while some develop a more aggressive form and metastasize to other body parts that can be potentially lethal. Currently, the Prostate Cancer domain constitutes an immensely robust pipeline with more than 200 drugs under different phases of development. Even along with the presence of so many therapeutic drugs, Prostate Cancer remains the second most common cause of cancer death in American men and its incidence has doubled over the past two decades. DelveInsight presents a new addition to its newsletter edition that focuses on the Prostate Cancer market. The newsletter offers a complete picture of the Prostate Cancer market landscape, ongoing clinical trials, pipeline therapies that are expected to transform the Prostate Cancer market in the coming decade. Gain rich insights into Prostate Cancer epidemiological insights, current treatment therapies, details of the latest news and happenings, mergers and collaborations, critical pharmaceuticals involved, licensing deals along with events and top-level conferences taking place in the Prostate Cancer field. 1/6

  2. Interested in knowing more about what upcoming years hold for the Prostate Cancer market and how pharma companies are working to push the drug development? Download our Newsletter by simply filling up the form towards the right. Subscribe to our mailing list and stay informed about all the recent breakthroughs in the Oncology market. Know More About What's Covered:- · Indication overview · Signs, symptoms, and diagnosis · Epidemiological trends · Treatment approaches · R&D in the field · Top conferences · News flash · Recent Research Activities · Support from International organizations · Market insights · Prostate Cancer Market Dynamics · Collaborations and deals in the domain Download Prostate Cancer newsletter- https://www.delveinsight.com/whitepaper-newsletter/prostate-cancer- market 2. Chronic Obstructive Pulmonary Disease Newsletter 2/6

  3. Chronic Obstructive Pulmonary Disease Newsletter According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death globally. It is a poorly reversible disease of the lungs caused due to airflow limitation by noxious particles or gases, making it difficult to breathe. Although currently, there is no permanent cure found for Chronic Obstructive Pulmonary Disease, this condition is treatable to some extent. DelveInsights estimates a robust COPD pipeline with more than 40 drugs in the Chronic Obstructive Pulmonary Disease treatment market, expected to transform the market outlook. Get a detailed picture of the disease, its signs and symptoms, causes, and diagnostics tests. Learn more about its Chronic Obstructive Pulmonary Disease epidemiological statistics, current COPD treatment scenario, marketed drugs, and unmet needs in the market through our newsletter. Gain rich insights into the entire COPD market landscape, pipeline therapies, ongoing clinical trials with significant pharmaceuticals involved, details of the recent news and happenings, mergers and collaborations, licensing deals, and top conferences expected to occur in the Chronic Obstructive Pulmonary Disease space. Subscribe to our mailing list and stay informed about all the recent breakthroughs in the Respiratory and Lung Diseases market. Download our newsletter by simply filling up the form towards the right and stay in touch to learn more about our offerings and services. Know More About What's Covered: 3/6

  4. · Indication overview · Signs, symptoms, and diagnosis · Epidemiological trends · Treatment approaches · R&D in the field · Top conferences · News Flash · Recent Research Activities · Support from International organizations · Market insights · Chronic Obstructive Pulmonary Disease Market Dynamics · Collaborations and deals in the domain Download Chronic Obstructive Pulmonary Disease Newsletter- https://www.delveinsight.com/whitepaper-newsletter/chronic-obstructive- pulmonary-disease-market 3. Dry Age-related Macular Degeneration Newsletter 4/6

  5. Dry Age-related Macular Degeneration Newsletter Dry Age-related Macular Degeneration (Dry AMD), also called atrophic AMD, is the most common form of Age-related Macular Degeneration. It is caused due to the appearance of small yellowish deposits called drusen under the eye's retina. Currently, the Dry Age-related Macular Degeneration domain comprises a highly robust pipeline with more than 40 drugs under different phases of development. Although there are many drugs in various stages of clinical trials, there's still no curative treatment for Dry Age-related Macular Degeneration as of now. Learn more about Dry Age-related Macular Degeneration, its causes, symptoms, diagnosis, and available treatments through our newsletter. It brings to you rich insights into Dry AMD marketed therapies as well as emerging Dry AMD pipeline therapies, epidemiological statistics, and key companies operating the Dry AMD market. DelveInsight's Dry Age-related Macular Degeneration newsletter covers the recent news and happenings in the Dry AMD therapeutics market domain, ongoing clinical trials, drugs approvals, novel drug launches, prevailing unmet needs, market dynamics shaping the Dry Age-related Macular Degeneration market landscape, mergers and collaborations, licensing deals, and top conferences occurring in the Dry AMD therapy market domain. Subscribe to our mailing list and stay informed about all the recent breakthroughs in the Age-related Macular Degeneration market. Track recent updates in the Dry Age-related Macular Degeneration domain by downloading our newsletter; simply fill the form towards the right and stay in touch to learn more about our offerings and services. 5/6

  6. Know More About What's Covered: · Indication overview · Signs, symptoms, and diagnosis · Epidemiological trends · Treatment approaches · R&D in the field · Top conferences · News flash · Recent Research Activities · Support from International organizations · Market insights · Dry Age-related Macular Degeneration Market Dynamics · Collaborations and deals in the domain Download Dry Age-related Macular Degeneration Newsletter- https://www.delveinsight.com/whitepaper-newsletter/dry-age-related- macular-degeneration 6/6

More Related